Galvez, CM, Blanco-Colio, L, Picatoste, B, Ortega-Villanueva, L, Mendez-Barbero, N, Oller-Pedrosa, J, Escola-Gil, JC, Bellis, S, Rabinovich, G, Martin-Ventura, JL. Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.157. PMID:. IF:13.300(Q1/1D).

Alen, A, Muñoz, C, Soriano-Amores, M, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermúdez-Jiménez, J, Limeres, J, Tiron, C, Martínez-Alvarez, E, Cabrera-Romero, E, García-Pavía, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Moliner-Abós, C, Moris, G, Carrillo-Mora, LM, Syrris, P, Alvarez-Velasco, R, Gimeno, JR, Lorca, R. Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study. JACC-ADVANCES. 2026; 5(5)DOI:10.1016/j.jacadv.2026.102771. PMID:42202377. IF:(Q/D).

Martinez, GG, Padro, T, Guala, A, Fernandez, R, Garcia-Elias, A, Borrell-Pages, M, Olivero, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodriguez-Palomares, JF, Vilahur, G. HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.071. PMID:. IF:13.300(Q1/1D).

Chavez, REE, De Isla, LPP, Casanas, MC, Romero, MJR, Badimon, LB, Vilahur, GV, Mata, PM, Padro, TP. MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.002. PMID:. IF:13.300(Q1/1D).